Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Maya Zeineddine"'
Publikováno v:
Handbook of Medical and Health Sciences in Developing Countries ISBN: 9783030747862
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48d1caafdb9aa7cb81d61b0122c53589
https://doi.org/10.1007/978-3-030-74786-2_47-1
https://doi.org/10.1007/978-3-030-74786-2_47-1
Autor:
Maya Zeineddine, Farid Boumediene, Amal Al-Hajje, Pascale Salameh, Joelle Massouh, Georges Saab, Raed Al-Roughani, Akram Al-Mahdawi, Nevin Shalaby, Jihad Inshasi, Mohamad Ali Sahraian, Riadh Gouider, Saloua Mrabet, Jaber Al-Khabouri, Vahid Shaygannejad, Amina Chentouf, Bassem Yamout
Publikováno v:
Multiple Sclerosis and Related Disorders. 71:104369
Autor:
Maya Zeineddine, Farid Boumediene, Amal Al-Hajje, Pascale Salemeh, Anne Helme, Michael Thor, Bassem Yamout
Publikováno v:
Multiple Sclerosis and Related Disorders. 71:104267
Autor:
Ghida Ismail, Malak Issa, Taghrid El-Hajj, Hassan Tfaily, Mohamad Dassouki, Elie Assaf, Halim Abboud, Pascale Salameh, Amal Al-Hajje, Farid Boumediene, Bassem Yamout, Maya Zeineddine
Publikováno v:
Multiple Sclerosis and Related Disorders. 71:104328
Publikováno v:
Multiple sclerosis and related disorders. 52
Background The epidemiology of multiple sclerosis (MS) has been studied in many countries of the Middle East but the prevalence and incidence of MS in Lebanon is still unknown. Objectives To determine the incidence and prevalence of MS in Lebanon. Me
Autor:
Maya Zeineddine, Bassem Yamout
Publikováno v:
Multiple Sclerosis Journal-Experimental, Translational and Clinical
Multiple sclerosis was long considered a relatively rare entity in the Middle East, but research over the past 10 years and the publication of the Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis guidelines for mult
Autor:
M.A. Sahraian, Hani Tamim, Maya Zeineddine, Johnny Nicolas, Nabil K. El Ayoubi, Bassem Yamout, Samia J. Khoury
Publikováno v:
Multiple Sclerosis and Related Disorders. 24:113-116
Objective It is postulated that extending the dosing interval of natalizumab (NTZ) from 4 to 5–8 weeks might decrease the risk of progressive multifocal leukoencephalopathy (PML). The aim of this study was to assess the effect of extended interval
Autor:
Maya Zeineddine, Jihad Inshasi, Maurice Dahdaleh, Raed Alroughani, Saeed Bohlega, Mohammad Al-Jumah, Riadh Gouider, Bassem Yamout, Magd Zakaria
Publikováno v:
Multiple Sclerosis and Related Disorders
Patients with multiple sclerosis (MS) should be vaccinated against COVID-19. All COVID-19 vaccines are effective and do not appear to carry any additional risk for patients with MS. Patients with MS should get a COVID-19 vaccine as soon as it becomes
Autor:
Yehya El Kouzi, Jasem Y. Al-Hashel, Raed Alroughani, Raed Behbehani, Saeed Akhtar, Maya Zeineddine, Nabil K. El Ayoubi, Bassem Yamout, Samia J. Khoury, Samar Farouk Ahmed
Publikováno v:
Multiple sclerosis and related disorders. 34
Background Relapse rate in women with Multiple Sclerosis (MS) is reduced during pregnancy especially in the third trimester according to the previous studies. Objectives To measure the annual relapse rate (ARR) in women with MS during pregnancy. Meth
Autor:
Hassan Doumiati, Samar Farouk Ahmed, Mohammed Al Jumah, Jasem Yousef Al-Hashel, Saeed Akhtar, Raed Alroughani, Maya Zeineddine, Sahar Farhat, Bassem Yamout, Samia J. Khoury, Mohammad Ali Sahraian
Publikováno v:
Journal of the Neurological Sciences. 360:61-65
Objectives To estimate JCV seroprevalence and risk of seroconversion against JCV among MS patients in the Middle East. Methods This multicenter study was conducted by implementing a cross-sectional design to assess JCV seroprevalence, and a longitudi